XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 54,842.86%7.69M | 14.59%-2.95M | 102.97%526K | -174.76%-16.65M | 170.05%4.49M | 101.00%14K | -927.98%-3.45M | -945.51%-17.71M | -123.31%-6.06M | -589.17%-6.41M |
Net income from continuing operations | 174.34%1.62M | 66.39%-1.97M | 54.46%-3.42M | -37.37%-12.25M | 203.88%3.29M | 9.03%-2.18M | -1,696.32%-5.86M | -147.54%-7.51M | -114.76%-8.92M | -154.41%-3.17M |
Operating gains losses | ---- | ---- | ---- | -21.94%-4.32M | 65.20%-111K | ---412K | 80.66%-462K | -300.12%-3.33M | 95.09%-3.54M | 95.30%-319K |
Depreciation and amortization | 0.18%2.72M | -31.71%1.66M | -19.70%1.72M | 64.32%10.54M | 97.88%3.27M | 62.24%2.71M | 52.90%2.43M | 41.90%2.14M | -19.12%6.42M | -7.14%1.65M |
Other non cash items | -26.05%562K | -40.13%567K | -3.07%726K | -1.45%3.19M | -13.21%736K | 25.00%760K | 66.14%947K | -38.25%749K | 4,398.61%3.24M | 1,513.33%848K |
Change In working capital | 248.09%2.33M | -265.53%-3.86M | 106.99%721K | -118.54%-16.47M | 40.73%-3.53M | 12.72%-1.57M | 0.28%-1.06M | -908.23%-10.31M | -29.69%-7.54M | -152.74%-5.95M |
-Change in receivables | 80.43%-779K | -1,893.47%-4.88M | 36.13%5.26M | -293.67%-2.26M | -6,250.00%-1.91M | -219.76%-3.98M | -170.20%-245K | 84.58%3.87M | -22.69%1.17M | -100.69%-30K |
-Change in inventory | -3.77%3.98M | 90.39%-253K | 46.37%-1.24M | 73.46%-2.57M | 28.57%-1.76M | 231.56%4.14M | -53.14%-2.63M | 1.99%-2.31M | -794.84%-9.69M | -8.83%-2.46M |
-Change in prepaid assets | -43.85%776K | 97.30%-31K | -68.24%1.07M | 645.32%4.78M | 927.83%1.18M | 751.89%1.38M | -2,024.07%-1.15M | 563.45%3.36M | 57.56%-876K | 105.62%115K |
-Change in payables and accrued expense | 58.83%-790K | -57.56%1.66M | 75.18%-3.48M | -1,223.93%-12.06M | 98.98%-28K | -144.26%-1.92M | 457.92%3.91M | -336.92%-14.03M | -117.53%-911K | -197.47%-2.74M |
-Change in other current assets | 63.55%-277K | 77.86%-533K | -16.08%-556K | -2,043.67%-4.76M | 40.98%-1.12M | 5.71%-760K | -1,283.33%-2.41M | -115.37%-479K | 105.74%245K | -624.52%-1.89M |
-Change in other current liabilities | -35.43%-581K | -87.65%181K | 54.01%-333K | -83.67%412K | -90.63%99K | 41.31%-429K | 1,010.56%1.47M | -130.69%-724K | 133.28%2.52M | 121.39%1.06M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 54,842.86%7.69M | 14.59%-2.95M | 102.97%526K | -174.76%-16.65M | 170.05%4.49M | 101.00%14K | -927.98%-3.45M | -945.51%-17.71M | -123.31%-6.06M | -589.17%-6.41M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -94.21%-13.25M | -153.18%-19.2M | -233.00%-9.65M | -519.25%-28.54M | -325.09%-11.23M | -108.56%-6.82M | -534.92%-7.59M | -559.91%-2.9M | -110.38%-4.61M | -148.56%-2.64M |
Net PPE purchase and sale | -100.66%-13.29M | -180.35%-19.17M | -170.69%-9.6M | -259.17%-27.52M | -285.76%-10.51M | -103.72%-6.63M | -1,997.55%-6.84M | -160.85%-3.55M | -44.38%-7.66M | -241.35%-2.72M |
Net business purchase and sale | --0 | --0 | --0 | --48K | --0 | --0 | --0 | --48K | --0 | --0 |
Net other investing changes | 86.54%-82K | 97.19%-34K | -34.21%-51K | -361.41%-2.69M | -250.42%-834K | -3,105.26%-609K | -418.88%-1.21M | 59.14%-38K | 58.30%-583K | -75.00%-238K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -94.21%-13.25M | -153.18%-19.2M | -233.00%-9.65M | -519.25%-28.54M | -325.09%-11.23M | -108.56%-6.82M | -534.92%-7.59M | -559.91%-2.9M | -110.38%-4.61M | -148.56%-2.64M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 4,614.29%25.74M | 3,376.07%15.33M | -104.36%-1.01M | 1,464.44%22.91M | -27.68%-429K | 271.16%546K | -18.18%-468K | 3,803.82%23.26M | 90.42%-1.68M | -202.70%-336K |
Net issuance payments of debt | -0.74%-409K | 7.71%-419K | -105.06%-414K | -28.65%-1.6M | -2,581.38%-8.93M | -27.27%-406K | -23.37%-454K | 3,722.12%8.19M | 92.75%-1.25M | -217.14%-333K |
Net common stock issuance | 2,646.74%26.15M | 112,607.14%15.75M | -103.97%-599K | 4,221.13%15.99M | -633.33%-22K | --952K | -366.67%-14K | 4,046.07%15.07M | -57.72%-388K | 40.00%-3K |
Cash dividends paid | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 51.61%-45K | --0 |
Net other financing activities | ---- | ---- | ---- | --8.52M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 4,614.29%25.74M | 3,376.07%15.33M | -104.36%-1.01M | 1,464.44%22.91M | -27.68%-429K | 271.16%546K | -18.18%-468K | 3,803.82%23.26M | 90.42%-1.68M | -202.70%-336K |
Net cash flow | ||||||||||
Beginning cash position | -44.96%37.2M | -44.34%44.02M | -29.15%54.15M | -13.91%76.43M | -28.55%61.32M | -25.58%67.58M | -11.93%79.09M | -13.91%76.43M | 147.08%88.78M | 4.49%85.82M |
Current changes in cash | 422.31%20.18M | 40.71%-6.82M | -481.26%-10.13M | -80.43%-22.28M | 23.67%-7.17M | -25.34%-6.26M | -1,237.06%-11.51M | 158.81%2.66M | -123.37%-12.35M | -241.41%-9.39M |
End cash Position | -6.43%57.38M | -44.96%37.2M | -44.34%44.02M | -29.15%54.15M | -29.15%54.15M | -28.55%61.32M | -25.58%67.58M | -11.93%79.09M | -13.91%76.43M | -13.91%76.43M |
Free cash flow | 12.99%-5.75M | -114.92%-22.12M | 57.32%-9.07M | -194.95%-44.17M | 34.24%-6.02M | -40.81%-6.61M | -451.55%-10.29M | -2,991.16%-21.25M | -175.64%-14.98M | -1,883.43%-9.15M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |